Research interests include Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, and Lymphoma Diagnosis and Treatment.
Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria
British Journal of Clinical Pharmacology2025cited by 6position: middledoi
Subcutaneous Mosunetuzumab Is Active with a Manageable Safety Profile in Patients (pts) with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphomas (B-NHLs): Updated Results from a Phase I/II Study